RxDoctor Payments Data

Emily Purdy

Physician Assistant · Baltimore, MDNPI 1437600640

Payments from drug & device makers

$5,469in general payments, 2019–2025

Across 269 payments — averaging $20.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$705
  • Corcept Therapeutics$640
  • AstraZeneca$461
  • Abbott$412
  • Bayer$359
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,38098%
  • Education$892%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,469 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide70$97,186
FarxigaDapagliflozin Propanediol70$76,195
MounjaroTirzepatide50$61,899
EliquisApixaban58$55,960
JardianceEmpagliflozin48$54,017
OzempicSemaglutide52$50,852
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$35,832
RybelsusSemaglutide15$27,203
Soliqua 100-33Insulin Glargine/Lixisenatide26$27,039
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$22,425
EntrestoSacubitril/Valsartan15$18,952
LinzessLinaclotide13$15,936
Tresiba Flextouch U-200Insulin Degludec19$13,052
JanuviaSitagliptin Phosphate11$9,951
MovantikNaloxegol Oxalate23$9,627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$705$159,085120 claims
AstraZenecaFarxiga, Breztri Aerosphere$461$98,62097 claims
Novo NordiskOzempic, Rybelsus$1,075$78,05567 claims
PfizerEliquis$251$55,96058 claims
Boehringer IngelheimJardiance$41$54,01748 claims
GSKTrelegy Ellipta$228$35,83245 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$270$27,03926 claims
NovartisEntresto$65$18,95215 claims
AbbVieLinzess$98$15,93613 claims
MerckJanuvia$50$9,95111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →